ASX: ALA Arovella Therapeutics Limited ACN 090 987 250 ASX Release 5 November 2026 AMENDED CONSTITUTION MELBOURNE, AUSTRALIA 5 November 2026: Arovella Therapeutics, (ASX: ALA), attaches a copy of the Company’s amended constitution incorporating an amendment to clause 50(c) and the insertion of...